| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 07/17/2013 | CN103209964A Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 07/17/2013 | CN103209960A Sulfonamide compounds useful as CYP17 inhibitors |
| 07/17/2013 | CN101641339B Compounds for the prevention and treatment of cardiovascular diseases |
| 07/17/2013 | CN101374815B Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 07/16/2013 | US8487116 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 07/11/2013 | US20130178612 Chiral auxiliaries |
| 07/11/2013 | US20130178457 Cannabinoid receptor modulators |
| 07/11/2013 | US20130178417 Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 07/10/2013 | EP2611780A1 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators |
| 07/09/2013 | US8481532 PDE-10 inhibitors |
| 07/04/2013 | US20130172310 Benzamides and related inhibitors of factor xa |
| 07/02/2013 | US8476297 TRP-M8 receptor ligands and their use in treatments |
| 06/27/2013 | WO2013093842A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 06/27/2013 | WO2013092756A1 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | CA2858328A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/26/2013 | EP2606893A1 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application |
| 06/25/2013 | US8470842 Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor |
| 06/25/2013 | CA2562082C Cetp inhibitors for the treatment and prevention of atherosclerosis |
| 06/20/2013 | WO2013087934A1 Cationic para-phenylenediamines, composition comprising at least such compounds, implementation process therefor and use thereof |
| 06/20/2013 | US20130158015 Dual mechanism inhibitors for the treatment of disease |
| 06/19/2013 | EP2603493A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 06/19/2013 | EP2603217A1 Novel 6,7-disubstituted-isoquinoline derivatives and their use |
| 06/19/2013 | CN103159677A 1-phenyl-1, 2, 3, 4-tetrahydroisoquinoline preparation method |
| 06/19/2013 | CN103159646A Hydroxamic acid compound, and preparation method and application thereof |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | CA2524047C Immunosuppressant compounds and compositions |
| 06/13/2013 | US20130150403 Nuclear receptor binding agents |
| 06/12/2013 | CN103145616A Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 06/12/2013 | CN101445422B Organic electroluminescent material and application thereof |
| 06/11/2013 | US8461329 Isoquinoline derivative |
| 06/11/2013 | CA2577837C Diarylsulfones as 5-ht2a antagonists |
| 06/06/2013 | WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 06/06/2013 | US20130143874 Fused ring pyridine compound |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | CA2850700A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/05/2013 | EP2599774A1 Condensed ring pyridine compound |
| 06/05/2013 | EP2598481A1 Sulfonamide compounds useful as cyp17 inhibitors |
| 06/05/2013 | CN103140221A Novel heterocyclic derivatives and pharmaceutical composition containing same |
| 06/05/2013 | CN102083796B Trisubstituted 3,4-dihydro-1H-isoquinolin compound, process for its preparation, and its use |
| 06/05/2013 | CN101583601B Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2 |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/04/2013 | US8455647 6-aminoisoquinoline compounds |
| 06/04/2013 | US8455515 Kidney and respiratory system disorders; central nervous system disorders; brain disorders; sleep disorders; strokes; psychological disorders |
| 06/04/2013 | US8455513 Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 05/30/2013 | WO2013076090A1 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors |
| 05/30/2013 | US20130137874 One-Pot Preparation of Hexahydroisoquinolines from Amides |
| 05/30/2013 | US20130137719 Novel 6,7-disubstituted-sioquinoline derivatives and their use |
| 05/30/2013 | US20130137718 Process for the preparation of 2-(cyclohexylmethyl)-n--1,2,3,4-tetrahydroisoquinoline-7-sulfonamide |
| 05/30/2013 | US20130137679 Novel Functionally Selective Ligands of Dopamine D2 Receptors |
| 05/30/2013 | CA2856759A1 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors |
| 05/29/2013 | EP2595960A1 Salt and solvates of a tetrahydroisoquinoline derivative |
| 05/29/2013 | EP2595620A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 05/29/2013 | EP2595485A1 Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders |
| 05/29/2013 | EP2595484A1 Methods of use of cyclic amide derivatives to treat schizophrenia |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/28/2013 | CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/23/2013 | US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY |
| 05/23/2013 | US20130131018 Substituted isoquinolines and their use as tubulin polymerization inhibitors |
| 05/22/2013 | EP2593431A2 Chemical compounds |
| 05/22/2013 | EP2593095A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 05/22/2013 | CN103119024A Isoquinoline derivative |
| 05/22/2013 | CN103113299A Method for preparing nelfinavir mesylate |
| 05/21/2013 | US8445682 Preparation of 3,4-dihydroisoquinolines from an acid and an amine |
| 05/16/2013 | WO2013070911A1 Compounds and methods for treating cystic fibrosis |
| 05/16/2013 | WO2013068489A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a |
| 05/16/2013 | US20130123503 Process for Synthesizing Substituted Isoquinolines |
| 05/16/2013 | CA2852820A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a |
| 05/15/2013 | EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 05/15/2013 | EP2590944A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 05/15/2013 | EP2590942A1 Rho kinase inhibitors |
| 05/15/2013 | CN103108548A Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders |
| 05/15/2013 | CN103102304A Preparation method of N-sulfonyl substituted tetrahydroisoquinoline derivatives |
| 05/14/2013 | US8440691 Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
| 05/09/2013 | US20130116318 Enzyme Inhibitors |
| 05/09/2013 | US20130116278 Antimicrobial agents |
| 05/09/2013 | US20130116277 Aldo-keto reductase subfamily 1c3 (akr1c3) inhibitors |
| 05/09/2013 | US20130116276 New use of neferine |
| 05/09/2013 | US20130116229 Novel inhibitor compounds of phosphodiesterase type 10a |
| 05/08/2013 | CN102026979B Process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative |
| 05/07/2013 | US8436182 Process for preparation of solifenacin and/or the pharmaceutically acceptable salts thereof of high pharmaceutical purity |
| 05/07/2013 | US8436029 Pharmaceutical forms, and methods of making and using the same |
| 05/07/2013 | US8435984 Tertiary amine substituted peptides useful as inhibitors of HCV replication |
| 05/07/2013 | US8435983 Conformationally restrained epothilone analogues as anti-leukemic agents |
| 05/02/2013 | WO2013060818A1 Novel process |
| 05/02/2013 | US20130109716 N-aminotetrahydroisoquinolines as anti-cancer agents |
| 05/02/2013 | US20130109715 6-Substituted isoquinolines and isoquinolinones |
| 05/02/2013 | US20130109708 Chemical Compounds |
| 05/02/2013 | US20130109685 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 05/02/2013 | US20130109652 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 05/01/2013 | EP2586772A1 Isoquinoline derivative |
| 04/30/2013 | US8431705 One-pot preparation of hexahydroisoquinolines from amides |
| 04/25/2013 | WO2013057251A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | WO2013005168A3 Cannabinoid receptor modulators |
| 04/25/2013 | CA2852750A1 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/24/2013 | CN103058929A Preparation method of octahydro isoquinoline derivative |
| 04/24/2013 | CN103058928A Preparation method of dextromethorphan intermediate 1-(4-methoxyl) benzyl-1,2,3,4,5,6,7,8-octahydro isoquinoline |